Brief: Intelgenx to regain exclusive worldwide rights to develop and commercialize rizaport(r)
Dec 5 (Reuters) - Intelgenx Technologies Corp IGX.V :
* INTELGENX TO REGAIN EXCLUSIVE WORLDWIDE RIGHTS TO DEVELOP
AND
COMMERCIALIZE RIZAPORT(R)
* INTELGENX TECHNOLOGIES - RECEIVED NOTICE REDHILL BIOPHARMA
INTENDS TO TERMINATE AGREEMENT WITH CO FOR CO-DEVELOPMENT &
COMMERCIALIZATION OF RIZAPORT
Source text for Eikon: ID:nMKWHGPKQa
Further company coverage: IGX.V
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Intelgenx Technologies
See all newsBrief: Intelgenx Obtains Court-Approval Of Sale & Investment Solicitation Process
Brief: Intelgenx Initiates Restructuring Proceedings Under CCAA To Implement Review Of Its Strategic Alternatives
Brief: Intelgenx Initiates Restructuring Proceedings Under The CCAA
Brief: IntelGenx Says First Parkinson’s Disease Patients Dosed With Montelukast VersaFilm in Mid-Stage Clinical Trial
Brief: IntelGenx Updates Status Of Buprenorphine Buccal Film ANDA